Joud Hajjar Texas Children's and colleagues identify distinct gut #microbiome profiles in common variable #immunodeficiency patients with noninfectious complications and establish a novel germ-free mouse model using fecal microbiota transplant. hubs.la/Q03jMvbf0

Congratulations Joud and team From the Labs at Baylor College of Medicine BCMHouston

🔔 JHI is delighted to share the Abstracts from the 2025 Clinical Immunology Society's (CIS) Annual Meeting: Immune Deficiency & Dysregulation, May 1-4 in Philadelphia and online! 🔗 Explore the Abstracts 👉 hubs.la/Q03k2VPF0 #ClinicalImmunology #CISMeeting

Kanegane et al review unresolved issues in the pathogenesis of X-linked agammaglobulinemia (XLA), incl. non-coding BTK variants, contiguous deletion syndrome, Helicobacter infection, non-infectious neurodegeneration, renal involvement & malignancies hubs.la/Q03k3slr0

Complete First Issue of Journal of Human Immunity is here! JHI is the official #OpenAccess journal of the International Alliance for Primary Immunodeficiency Societies #IAPIDS. Explore new research and the inaugural editorial from our EiC Casanova Lab 👉 hubs.la/Q03l62BG0

We were proud to be represented during the 6th APSID Congress and 3rd National Congress of Inborn Errors of Immunity & National Forum on Pediatric Immunology last month in Beijing, China! Learn more about our #IAPIDS Society Editors: hubs.la/Q03lCj880

Motoi Yamashita, Hirokazu Kanegane et al. report a questionnaire-based study that provides insights into the current healthcare infrastructure used to diagnose and manage #InbornErrorsOfImmunity across countries & regions involved in APSID. hubs.la/Q03mrLyD0

Healthcare resources for #InbornErrorsOfImmunity in the Asia-Pacific region. A new questionnaire-based study by Motoi Yamashita, Hirokazu Kanegane and colleagues: hubs.la/Q03mrPK40 APSID

“By identifying & promoting good science, treating authors with decency and respect, and ensuring quality of peer review, editors nurture the reputation and quality of journals.” Read the editorial by our sister journal LifeScienceAlliance's timisstuck: hubs.la/Q03nySFZ0

Nice therapeutic success ! Successful coil occlusion of intracranial aneurysm in a child with STAT3 hyper IgE syndrome rupress.org/jhi/article/1/…

Superb Review of an interesting type I interferonopathy ! Spondyloenchondrodysplasia: An enigmatic immuno-osseus type I interferonopathy rupress.org/jhi/article/1/…

Successful coil occlusion of intracranial aneurysm in a child with STAT3 hyper IgE syndrome. New study from Archan Sil, Pandiarajan Vignesh and colleagues (PGIMER, Chandigarh, India): hubs.la/Q03qGvKC0 #InbornErrorsOfImmunity

Spondyloenchondrodysplasia: An enigmatic immuno-osseus type I #interferonopathy. New review from Callie Wong, Tifenn Wauquier, Yanick Crow and colleagues Institute of Genetics and Cancer: hubs.la/Q03qGw9M0 #Autoinflammation

Materna, Vivien Béziat et al. @institutimagine report children with complete TCRα deficiency, a lack of αβ T cells, & a severe condition. Previously characterized TCRα deficiency, which wasn't as severe as expected, was partial, as opposed to complete hubs.la/Q03qMb0m0

🚨 Our first paper in Journal of Human Immunity just came out! We describe two forms of TCR⍺ deficiency: a complete and a partial form. 👉 doi.org/10.70962/jhi.2…

Please consider submitting your work to Journal of Human Immunity, the novel journal of the “Inborn Error of Immunity” community. It is published by the nonprofit Rockefeller U. Press

🔔 We're delighted to share the abstracts from the 4th Congress of the Arab Society for Primary Immunodeficiencies #ARAPID, which took place April 24–26, 2025, in Casablanca, Morocco. Explore the latest advancements in #PID clinical practice & research 👉 hubs.ly/Q03r1ZZC0

Rare #InbornErrorsOfImmunity affecting MHC class I expression can cause chronic infections & be mistaken for #autoimmune disease. New research highlights the need for infection-focused care & long-term follow-up. Review by Gadola, Ljunggren et al.: hubs.la/Q03rHl7q0

An infant who contracted Mycobacterium #tuberculosis revealed clinical manifestations suggestive of BCG infection. The identification of the Mycobacterium species is pivotal in determining the appropriate therapeutic regimen. From Espinosa-Padilla et al.: hubs.la/Q03s1yN_0

Guarnieri, Booth et al. show that topical ruxolitinib induced rapid and sustained improvement of refractory skin #inflammation in a child w/ STAT1 GOF disease, highlighting its potential in managing localized inflammation in immune dysregulation hubs.la/Q03sc6zv0